Podcasts about ocular

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of breakthroughs and strategic maneuvers that are reshaping the landscape of this dynamic industry.Roche is making waves with its antibody Gazyva, initially recognized for cancer treatment. The company has successfully ventured into autoimmune diseases, targeting kidney conditions. Recent phase 3 trials have reinforced Gazyva's efficacy in treating immune-mediated kidney diseases, building on its prior approval for lupus nephritis. This marks a potential paradigm shift from oncology to autoimmune therapy applications, offering a promising new avenue for treating complex kidney disorders. Such advancements underscore the power of immune modulation in addressing severe health conditions.Turning to oncology, Eli Lilly is expanding the use of its cancer drug, Retevmo. Originally approved for specific lung and thyroid cancers with rare biomarkers, Lilly is now exploring its use in the adjuvant setting for non-small cell lung cancer. This effort reflects a broader trend in oncology: companies are increasingly looking to extend the application of targeted therapies beyond their initial indications. This expansion could significantly enhance treatment options and improve patient outcomes.In ophthalmology, Ocular Therapeutix is preparing for an FDA filing following positive phase 3 results for its wet age-related macular degeneration treatment. Their candidate, AXPAXLI, showed superior efficacy compared to Regeneron's Eylea in head-to-head trials. Despite investor skepticism, Ocular remains confident in its product's potential to impact retinal disease management positively. The competitive landscape in ophthalmology is fierce, and innovative treatments with substantial clinical benefits over existing therapies can redefine standards of care.Eli Lilly is also strategically stockpiling Orforglipron, its oral GLP-1 candidate, in anticipation of FDA approval for obesity treatment. This proactive measure aims to prevent supply chain issues seen during previous GLP-1 launches. It reflects an industry-wide focus on ensuring product availability at launch to meet growing market demand effectively.On the regulatory front, there are significant shifts as well. The Trump administration's renewed pilot of 340B rebates aims to optimize drug pricing frameworks. Novartis has secured a long-term supply agreement with Niowave for Actinium-225 (Ac-225), crucial for developing targeted cancer therapies. This highlights the sustained demand for radiopharmaceutical isotopes as part of precision medicine initiatives.Biopharma funding is expected to recover steadily by 2026, albeit with a cautious approach favoring de-risked assets over broader platform technologies. Venture capitalists prefer predictable returns amidst an evolving market landscape.Now, let's turn to Japan, where Innovacell is planning a $92 million IPO on the Tokyo Stock Exchange. This move signals a renewed interest in biotech within the region after a long drought in IPOs. Financial strategies like these are vital for advancing cell therapies that hold promise for treating conditions once deemed challenging.Gilead Sciences has acquired synthetic lethal therapy from Genhouse Bio through a $1.5 billion deal, further underscoring the growing interest in synthetic lethality as a novel cancer treatment approach. This strategy focuses on targeting tumors while sparing normal cells, offering more effective therapies with fewer side effects.In mental health innovations, Compass Pathways has reported positive results from its pivotal trial using psilocybin for treatment-resistant depression. The success of this phase 3 trial highlights the potential role of psychedelics in psychiatric care and could revolutionize mental health treatments by providing new options Support the show

Ocular herpes and shingles are often misunderstood, misdiagnosed, and treated too late. In this episode, we break down herpes simplex virus (HSV) and herpes zoster affecting the eye, focusing on real world clinical insights that go far beyond textbook explanations. Whether you are an eye care professional, healthcare provider, medical student, or someone seeking reliable medical education, this conversation offers clear, practical, and evidence based insights into ocular viral disease.

In this episode of the Tick Boot Camp Podcast, Matt Sabatello sits down with Yuri Kim, the lead clinical research nurse for MIT's MAESTRO study, described as one of the largest studies in MIT history focused on Lyme disease and Infection-Associated Chronic Illnesses (IACI). Yuri explains how MAESTRO is collecting deep symptom histories and objective measurements—from eye tracking and EEG/P300 auditory testing to NASA Lean dysautonomia testing, capillaroscopy, and multi-sample biological collection—to identify patterns that validate patient experiences and accelerate real-world clinical understanding. Yuri's story is equally compelling: she began as an ER nurse in a Level 1 trauma center, transitioned into research nursing (including neurodegenerative and traumatic brain injury work), moved to South Korea during the pandemic, and ultimately joined MIT after a conversation with Dr. Mikki Tal changed the course of her career. Throughout the conversation, Yuri shares what she's learned from MAESTRO participants: a community often exhausted and dismissed, yet profoundly motivated to help others and drive scientific progress forward. Key Takeaways (Fast Scan) MAESTRO is nearing ~200 participants enrolled, with the chronic Lyme cohort full and enrollment closing soon. The study aims to objectively measure symptoms often dismissed as “anxiety” or “depression,” especially brain fog and dysautonomia. MAESTRO uses multiple cognitive and neurologic measures, including RightEye eye tracking, EEG + P300 auditory “oddball” testing, and remote cognitive battery tests. The team added capillaroscopy (nailfold and toe microvascular imaging) to explore vascular patterns and hemorrhages in chronic illness cohorts. Dysautonomia testing includes NASA Lean Test plus an earpiece device to estimate proxy cerebral blood flow, sometimes showing abnormalities even when vitals look “normal.” Extensive biological sampling (oral, blood, vaginal/rectal) supports proteomics/immune profiling and deeper molecular analysis. Yuri emphasizes: patients' willingness to participate—despite severe symptoms—is the engine of progress and future change. Detailed Chapter-by-Chapter Show Notes 1) Meet Yuri Kim: The Human Side of Cutting-Edge Lyme Research Matt introduces Yuri as the clinical research nurse leading day-to-day operations of MIT's MAESTRO study—positioning her as a rare bridge between lab science, clinicians, and patients. Yuri shares that the study is approaching enrollment completion and that the team is eager to analyze a large dataset to “speak up” for participants who have suffered without clear explanations. Highlights: MAESTRO is one of MIT's largest studies, with enrollment nearing completion. The mission is to transform patient suffering into measurable signals, data, and insight. 2) Yuri's Background: Pharma, ER Nursing, Research, and Why This Work Became Personal Yuri explains her path: early work as a medical information specialist in pharma (including literature searches and clinician guidance, often involving off-label questions), then an intense period as a Level 1 ER nurse where she witnessed both acute crises and chronic illness desperation. Key insight:Yuri notes that in pharma and ER settings, she repeatedly saw the same reality—patients searching for answers, clinicians constrained by time, and chronic illness voices falling through the cracks. 3) From the ER to Neuro Research: Brain Inflammation, TBI, and the Gap in Chronic Illness Care Yuri left ER work largely due to the physical toll of night shifts and moved into academic research at Boston University. She worked on complex studies involving Alzheimer's, amyloidosis, and traumatic brain injury. Matt asks whether Lyme came up in those neuro settings. Yuri says no—but now she views neurodegenerative symptoms differently and believes clinicians should consider underlying root causes, including infection. Listener connection:This segment reinforces how often Lyme-related cognitive decline can be misinterpreted or missed when viewed through siloed specialties. 4) Lyme Awareness Outside the U.S.: South Korea, Tick-Borne Illness, and Global Blind Spots During the pandemic, Yuri relocated to South Korea. She shares that Lyme isn't commonly discussed there, though other tick-borne illnesses exist. Yuri underscores a global concern: agricultural and rural communities face tick exposure without awareness of the chronic implications. 5) How Yuri Joined Dr. Mikki Tal and MAESTRO (And Why She Changed Her Mind) One of the most memorable segments: Yuri reveals she had already accepted another MIT nursing role—but after speaking with Dr. Tal, she pivoted immediately, calling it the best career decision she's ever made. Why it matters: It shows how MAESTRO is not just a study; it's a mission-driven effort that attracts top clinical talent. 6) Day One at MAESTRO: Meeting the Severely Ill and the Community's Unmatched Generosity Yuri recounts a powerful early experience: meeting a participant who was bedbound and profoundly symptomatic, yet eager to contribute anything possible to help the community. Matt connects this to Tick Boot Camp's origin story: people with minimal energy still showed up to help others. The theme becomes clear—Lyme patients are often depleted but relentlessly generous. What MAESTRO Measures (The Four-Hour Visit Breakdown) 7) Brain Fog: Why MAESTRO Treats It as a Complex Phenomenon Yuri explains MAESTRO's approach: brain fog isn't one symptom. It can involve memory, processing speed, visual stimulation sensitivity, pain-triggered cognition changes, and motor response delays. Core idea: MAESTRO attempts to measure brain fog from multiple angles—visual processing, auditory processing, reaction time, and executive function. 8) RightEye Eye Tracking: Visual Stimulus + Reaction Time as Objective Signal Participants complete a structured set of ocular motor tasks (pursuit, saccades) and reaction-time games (shape recognition mapped to numbered inputs). Yuri notes many chronic illness participants struggle even with basic saccades, often aligning with reported visual disturbances. What MAESTRO is measuring: Ocular motor control Visual processing Decision speed Reaction time consistency 9) EEG + P300 “Oddball” Test: Auditory Processing Meets Motor Output Participants wear an EEG cap (19 regions) and listen to tones: common low-pitch and rare high-pitch. They must press the spacebar only for the rare tone. Yuri notes that even a 4-minute test can be exhausting for people with cognitive dysfunction, and participants often describe a frustrating “delay” between knowing what to do and physically doing it. Why this matters: This may help validate cognitive dysfunction even when standard office screening looks normal. 10) Remote Cognitive Battery Testing: Scaling Measurement Beyond MIT Participants complete executive function tests at home (memory, Stroop-like color-word matching, trail-making tasks). Yuri emphasizes why this matters: many patients can't travel, and symptoms vary dramatically by day, cycle, and crash patterns. Big future direction: Remote testing could expand access to bedbound patients and capture “good day vs bad day” variability. 11) Dysautonomia & POTS: NASA Lean Test + Proxy Cerebral Blood Flow Yuri details NASA Lean testing: supine rest, then standing/leaning while monitoring vitals and symptoms. The standout: sometimes vitals appear stable while patients feel intensely symptomatic—yet the cerebral blood flow proxy measurement fluctuates significantly. Clinical implication discussed: This approach could become a tool for identifying dysautonomia-related issues when standard vitals “look fine.” 12) Capillaroscopy: Nailfold + Toe Microvascular Imaging MAESTRO added capillaroscopy to examine microvascular patterns, including abnormal shapes and possible hemorrhages seen more frequently in chronic cohorts (as her clinical observations suggest). They also measure capillaries pre- and post-NASA Lean to explore whether symptomatic shifts correlate with microvascular changes. Why patients find it meaningful: They can visually see something measurable that aligns with how they feel. 13) Standard Neuro Screening Doesn't Capture Lyme Brain Fog Yuri shares a crucial point: participants often perform fine on standard screens like the Mini-Mental State Exam, suggesting that infection-associated cognitive dysfunction can be subtle, dynamic, and not detected by traditional tools—reinforcing the need for MAESTRO-style measurement. Biological Samples: “Measure Everything” (Head to Toe) 14) Multi-Sample Collection: Oral, Blood, Vaginal, Rectal Yuri explains the breadth of biological sampling, including saliva/oral samples (cotton chew + gum swab), multiple blood tubes, and sex-specific sampling to explore immune, hormonal, microbiome, and gynecologic dimensions. Why it's being done: To connect symptom clusters to molecular patterns and explore sex differences in chronic illness response. 15) Storage, Batch Effects, and What Happens After Enrollment Closes Samples are aliquoted and stored at -80°C until they can be processed/shipped in ways that minimize batch effects. The next phase is analysis and collaboration—including proteomics and immune signaling exploration. 16) Giving Back to Participants: The Challenge and the Intention Yuri acknowledges the “fine line” between research-only testing and clinically actionable reporting, but stresses MIT's intention to return what can be responsibly shared through certified partners—while being careful not to over-interpret research findings. Collaboration, Scaling, and What Comes Next 17) Collaboration Across Institutions: The Missing Platform Matt compares Lyme research needs to cybersecurity threat-sharing between banks: competitors collaborate because the threat is bigger than any one organization. Yuri agrees and highlights the need for secure data-sharing platforms—similar to large national efforts in other fields. 18) What's Next: Focus on Female Brain Fog, Hormones, and Remote Studies Yuri previews upcoming directions: Brain fog and hormone cycle relationships Differentiating infection-associated cognitive dysfunction vs menopause-related brain fog Remote/at-home measurement studies to reach more symptomatic and bedbound patients Potential collaborations with pediatric and neuroimmune experts Closing Message: Hope Without Hype Yuri's message to patients and families is simple and emotional: “Please don't give up.” She believes answers are coming because serious teams are working together—and because patients are driving the research forward with their participation.

Guest: Courtney Crawford, MD, FACS Guest: Raj Maturi, MD While anti-VEGF therapy can deliver vision gains with consistent, frequent injections in clinical trials, it may be challenging to sustain this in real-world practice.1 Ocular gene therapy could be a potential option for patients with neovascular age-related macular degeneration if approved. With this approach, transgenes are delivered to the eye by adeno-associated viruses (AAVs).2-4 Learn more with Drs. Courtney Crawford and Raj Maturi, who shared their perspectives on investigational gene therapy, patient conversations, and surgical considerations at the 2025 American Academy of Ophthalmology annual meeting in Orlando, Florida. Dr. Crawford is a board-certified retina specialist and founder of Star Retina in Burleson, Texas. He previously served for 10 years as a physician in the U.S. Army, where he attained the rank of Lieutenant Colonel. Dr. Maturi is a board-certified retina specialist at the Midwest Eye Institute and founder of Retina Partners Midwest in Carmel, Indiana, where he focuses on macular, retina, and vitreous care. References: Weng CY, Singh RP, Gillies MC, Regillo CD. Optimizing visual outcomes in patients with neovascular age-related macular degeneration: the potential value of sustained anti-VEGF therapy. Ophthalmic Surg Lasers Imaging Retina. 2023;54:654–659. Petrich J, Marchese D, Jenkins C, Storey M, Blind J. …

This SEO-optimized clinical briefing is designed for the optometric community. It synthesizes the AOA Evidence-Based Optometry (EBO) Committee June 2025 clinical report with the professional insights of Dr. Andrew Morgenstern, Director of the AOA Clinical Resources Group, regarding the management of patients on GLP-1 receptor agonists.

Episode 3: Ocular Melanoma 101 & My Treatment Experience   Understanding a rare cancer can feel overwhelming — especially at the moment of diagnosis.   n Episode 3 of My 15 Years, Melody breaks down the basics of ocular melanoma (OM 101) in a clear, approachable way. She explains what ocular melanoma is, and how she felt as a newly diagnosed patients.   Melody also goes deeper into her personal treatment experience, sharing what plaque brachytherapy was like — from preparing for the procedure to living through treatment and recovery.   This episode is designed to help patients, caregivers, and loved ones better understand ocular melanoma, while grounding the information in real lived experience.   Rare Cancer. Resilient Hope. Revolutionary Research.

Sudden vision loss is not normal — and it's not something to "wait and see." If you've ever experienced a dark curtain, shadow, blur, or sudden vision change, this episode could be life-saving. In this episode of the Uncover Your Eyes podcast, Dr. Meenal Agarwal breaks down one of the most missed medical emergencies she sees in clinical practice: ocular stroke, a critical warning sign of serious vascular disease and future stroke risk. An ocular stroke is often the first red flag before a larger, more devastating neurological event. And yet, many people are told it's "just stress," "eye strain," or something that will pass.

A red, painful eye is not always allergies it can be ocular herpes, a serious infection that can permanently damage your vision if treated incorrectly. In Part 2, Dr. Mika Moy explains how herpes simplex virus (HSV) affects the eye, what herpes keratitis looks like, and why early symptoms are often missed. Learn how doctors identify the classic “dendrite” pattern on the cornea, why steroid eye drops can make the infection worse, and when antiviral treatment must start immediately.

A red eye is not always allergies or irritation it can be a sign of a serious eye infection. In this episode, we break down the real causes of red eye, including ocular herpes, chlamydia eye infections, and other conditions that are often misdiagnosed or ignored. Many of these infections can lead to permanent vision damage if they are treated too late or with the wrong eye drops. Learn how to recognize the warning signs that mean a red eye is an emergency, why “waiting it out” can be dangerous, and when common treatments can actually make things worse.

In this episode, Sam Ashoo, MD and T.R. Eckler, MD discuss the Januray 2026 Emergency Medicine Practice article, Emergency Department Diagnosis and Management of Patients With SyphilisSyphilis cases have surged 42% in the US, making it critical for emergency physicians to recognize and treat this "great masquerader." In this episode, hosts Sam Ashoo and Dr. T.R. Eckler break down the January 2026 Emergency Medicine Practice article on syphilis diagnosis and management. They cover the rising prevalence in high-risk populations, the four clinical stages (primary, secondary, latent, and tertiary), special presentations like neurosyphilis and congenital syphilis, and practical diagnostic approaches. With a national penicillin shortage, they discuss alternative treatment options including doxycycline and post-exposure prophylaxis. The conversation also addresses the dark history of the Tuskegee Study and its lasting impact on medical ethics. Whether you're seeing more cases in your ED or want to sharpen your diagnostic skills, this episode provides actionable insights for frontline providers.Timestamps[0:00] Opening/Introduction[0:11] Host Welcome & Resources[0:50] Episode Introduction[1:30] Epidemiology & Rising Cases[4:30] Risk Factors & Screening[6:30] Pathophysiology & Transmission[9:30] Primary Syphilis[12:30] Secondary Syphilis[15:30] Tertiary & Latent Syphilis[18:30] Neurosyphilis[22:30] Congenital Syphilis[25:30] Ocular & Otic Syphilis[28:30] Differential Diagnosis & Pre-hospital Care[31:30] History & Physical Examination[34:30] Diagnostic Testing Overview[38:30] Testing Details & Titers[41:30] Treatment: Penicillin & Alternatives[43:30] ClosingSubscribers, take the CME test here.Emergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net

Hoy hablamos con la Dra. Carmela Porcar, oftalmóloga y cirujana especializada en oculoplastia, blefaroplastia y estética facial. Carmela comparte su visión experta sobre cómo rejuvenecer la mirada respetando siempre la salud ocular y la naturalidad de la expresión. En este episodio descubriremos los secretos de la cirugía de párpados, cómo prevenir el envejecimiento de la zona periocular y la verdad médica sobre tendencias arriesgadas como el cambio de color de ojos. Un episodio lleno de claridad médica y honestidad estética. ► MARCAS DE TIEMPO: 00:00 Intro. 01:35 Trayectoria en oftalmología y oculoplastia. 02:47 Principales patologías y problemas palpebrales. 06:17 Consejos para cuidar el contorno. 09:59 Influencia genética versus cuidados diarios. 11:53 Psicología y expectativas del paciente. 16:06 Señales de salud en párpados. 18:06 Cánones de belleza y naturalidad. 20:05 Corrigiendo errores de otras cirugías. 24:10 Anestesia, cirugía y recuperación postoperatoria. 34:33 Costes y peligros del low-cost. 36:53 Alternativas no quirúrgicas: Botox, hialurónico. 38:33 Efectos de pantallas y luz. 40:11 Peligros al cambiar color de ojos. 46:27 Preparación y concentración del cirujano. 51:37 Dónde encontrar a Carmela Porcar. ▬▬▬▬ DÓNDE ENCONTRAMOS AL INVITADO ▬▬▬▬ Encontramos a la Dra. Carmela Porcar en: Web - https://doctoracarmelaporcar.es/ Ln - https://www.linkedin.com/in/carmela-porcar-plana-443262185/ Perfil Quirón Salud - https://www.quironsalud.com/inst-oftalmologico/es/equipo-medico/dra-carmela-porcar-plana ▬▬▬▬ INFO GENERAL ▬▬▬▬▬▬ Si te gusta el Podcast de SIIL, no olvides darle al ME GUSTA, dejarnos un comentario en tu plataforma de podcasts favorita, y registrarte en la newsletter de SIIL donde compartimos experiencias, consejos y mucha información sobre alopecia, salud, hábitos, nutrición y descanso: Crea hábitos y verás resultados. Suscríbete a nuestra newsletter para recibir más información sobre salud en nuestra web y blog: https://getsiil.com/ Suscríbete a nuestro podcast donde lo estés escuchando y a nuestro canal de YouTube: https://www.youtube.com/channel/UCj0P7unnZoHsUy6IUsIGkKQ?sub_confirmation=1 ▬▬▬▬▬▬▬ ¿QUIERES APRENDER MÁS? ▬▬▬▬▬▬▬▬ Si quieres mejorar tu salud capilar y de la piel, en SIIL ofrecemos recursos detallados en nuestra newsletter. Suscríbete a nuestra newsletter AQUÍ y recibe un ebook de regalo https://getsiil.com/pages/ebook-la-cura-de-la-calvicie-2 Además, recuerda que tenemos un suplemento antienvejecimiento que activa la telomerasa, productos 100% naturales para cabello y piel y packs ahorro que te ayudarán a Vivir joven más tiempo: ⏳ Suplemento ANTIEDAD https://getsiil.com/products/suplemento-antienvejecimiento-telomerasa-longevidad-celular ‍♂️ Productos CABELLO https://getsiil.com/collections/cabello-coleccion-manual Productos PIEL https://getsiil.com/collections/piel-coleccion-productos-individuales Packs Ahorro https://getsiil.com/collections/packs-ahorro ️ Todos nuestros productos https://getsiil.com/collections/all/todos

While jogging in 2023, Tessa Parry-Wingfield felt an unusual sensation in her left eye.  It wasn't painful but merited medical attention.  She was seen by three doctors before learning she had ocular melanoma, a form of eye cancer.  Because of the particulars of her diagnosis, she had to undergo an enucleation, the removal of her cancerous eye.  With an acrylic implant taking the place of the cancerous eye, Tessa had an enormous amount of learning ahead of her, most notably what is known as monocular vision.  Amazingly, Tessa has adjusted to her limited vision.  She has resumed running and hiking and driving a car.  Her future includes writing a book and climbing Mt. Kilimanjaro.   Tessa was jogging along the River Thames in London when she felt something was wrong with her left eye.  She went to see an optician thinking she needed to change her prescription regarding her contact lenses.  However, upon checking out Tessa's eyes, the optician could see something was wrong, perhaps an astigmatism.   Lacking the necessary equipment for more in-depth scrutiny, the optician sent Tessa to an eye hospital, where they performed various x-rays and scans.  When one of the x-rays of her left eye was held up for observation, half of it was black.  Her care team thought Tessa had a form of eye cancer known as ocular melanoma, or, uveal melanoma, a tumor in the eye.  She was next sent to see an ocular oncologist, who swiftly confirmed the diagnosis.   Many patients diagnosed with ocular melanoma have more than one treatment option, but in Tessa Parry-Wingfield's case, the oncologist performed more scans and tests and immediately told her she would need to undergo an enucleation, the removal of her left eye.    Tessa was under anesthesia for the 90-minute procedure.  It resulted in her getting a temporary prosthetic eye, eventually replaced by an acrylic implant, which she has to this day.   She had to do a great deal of learning to go through daily life with one functioning eye, but that is exactly what Tessa has done.  She has resumed running, hiking and skiing.  She thought it would be a year or so of adjustments before she could drive a car, but her vision tests went so well that, three months after the procedure, her oncologist urged her to get behind the wheel.  Without a left eye, she says she has to look a little farther to the left than she was used to before her diagnosis, but she is now quite comfortable driving a car.   Through her cancer experience, Tessa Parry-Wingfield says she has surprised herself by learning how tough and resilient she can be.   Additional Resources:   Tessa on Instagram: @seeing_life_clearly   Tessa's website: https://www.tessa.parry-wingfield.com  

What if simply *looking* at art could help regulate your nervous system, calm your mind, and restore emotional balance? In this deeply moving episode of HIListically Speaking, host Hilary Russo sits down with LeeAnn Heltzel, multidimensional artist, conscious explorer, and creator of MetaArt; frequency-infused abstract artwork designed as portals for ocular (eyes-open) meditation. They discuss the art form, the benefits, and the connection to Millions Meditating Alliance, the UN's World Meditation Day, and how you can join them for the healing.   MEDITATE WITH THE MILLIONS MEDITATING ALLIANCE (World Meditating Day - Dec 21) https://millionsmeditatingnow.com/   REGISTER & JOIN HILARY FOR THE UN WORLD MEDITATION DAY HAVENING HAPPY HOUR https://us02web.zoom.us/meeting/register/TH-dsgnrThKwm-kol4CjHQ   CONNECT WITH LEEANN https://www.leeannheltzel.com/ https://www.instagram.com/Leeannheltzel https://www.tiktok.com/@meta.artist   Use the code HUGITOUT20 for 20% off any MetaArt reproduction or commission. https://www.leeannheltzel.com/store   JOIN ME ON SUBSTACK - THE BRAIN CANDY BLUEPRINT! ⁣https://substack.com/@hilaryrusso ⁣ GET BRAIN CANDY & WAYS TO BE KIND TO YOUR MIND DELIVERED TO YOUR INBOX⁣ https://www.hilaryrusso.com/braincandy⁣ DISCOVER HAVENING TECHNIQUES TRAININGS & WORKSHOPS⁣ https://www.hilaryrusso.com/training⁣ ⁣ BOOK HILARY FOR YOUR NEXT EVENT OR ATTEND!⁣ https://www.hilaryrusso.com/events⁣ ⁣ CONNECT WITH HILARY⁣ https://www.linkedin.com/in/hilaryrusso⁣ https://www.instagram.com/hilaryrusso⁣ https://www.instagram.com/hilisticallyspeaking⁣ https://www.youtube.com/hilaryrusso⁣ https://www.hilaryrusso.com/podcast⁣ ⁣ MUSIC by Lipbone Redding⁣ https://www.lipbone.com⁣

Today's guest is Tessa Parry-Wingfield, global communications consultant, public speaker, and survivor of ocular melanoma, a very rare form of eye cancer that affects about 6 people per million annually. She has found purpose in her adversity and ironically "sees life clearly" despite her vision issues.We talk about learning to live with a prosthetic eye and monocular vision, the challenges of rare cancers, eye and vision health (see your eye doctor regularly), finding purpose and clarity post diagnosis, and so much more!Resources:Tessa's Website: Tessa Parry-Wingfield | Speaker + Storyteller | Seeing life clearly |Tessa's Instagram: https://www.instagram.com/seeing_life_clearly/Tessa's LinkedIn: Tessa Parry-Wingfield | LinkedInFollow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

“Olivia Colman, calm down.”This week's scariest movie is... Hot Fuzz. This film has everything: Ocular patdowns. A loose swan. And a the most charming bond to walk the earth. If you love buddy-cop bromance, murder-murder-murder chants, and suggestive headlines, this episode's for you!Please Subscribe, Rate, and Review The Horror Virgin to help more people discover our community.What did you think of our episode on Hot Fuzz? Tell us on social media @HorrorVirgin (Facebook/Instagram), @HorrorVirginPod (Twitter).Up Next: Krampus (2015)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In the November 2025 episode of Critical Decisions in Emergency Medicine, Drs. Danya Khoujah and Wendy Chang discuss acute radiation sickness and ocular foreign bodies. As always, you'll also hear about the hot topics covered in the regular features, including recurrent palpitations in a middle-aged man in The Critical ECG, primary adrenal insufficiency in Clinical Pediatrics, Lisfranc injury in Critical Cases in Orthopedics and Trauma, active external rewarming of hypothermic patients in The Critical Procedure, managing patients with acute visual loss in The LLSA Literature Review, abdominal pain in a child after a fall in The Critical Image, acetylcysteine for acetaminophen toxicity in The Drug Box, and carbon monoxide toxicity in The Tox Box.

Welcome to Session 1 of the Eye Believe Survivorship Seminar 2025! This 8:00 AM session features renowned ocular oncologist Dr. MATERIN (Duke Health) as he presents “Yesterday, Today & Tomorrow in Ocular Melanoma.” In this powerful opening session, Dr. Materin walks attendees through:

In this episode, we sit down with Vanessa Tompkins, wife and caregiver to Mike, who has been battling Stage 4 metastasized ocular melanoma. Over the past five years, Vanessa has supported Mike through weekly immunotherapy, four major surgeries—including the removal of his left eye, liver surgery, triple hernia repair, and open-heart surgery—and countless challenges along the way.A registered nurse, former hospice nurse, and current Sexual Assault Forensic Examiner, Vanessa brings professional expertise, personal experience, and unwavering compassion to her role as a caregiver. She is also a mother of three, grandmother of four, and devoted owner of her golden lab, Romeo. Guided by her motto, “One day at a time,” Vanessa shares insights into the realities of caregiving, the emotional resilience required, and the lessons learned in supporting a loved one through a complex and ongoing cancer journey.Tune in to hear her story, practical tips, and heartfelt reflections on the challenges and rewards of being a caregiver.

Contributor: Taylor Lynch, MD Educational Pearls: What is orbital compartment syndrome, and how is it assessed in the emergency room? Orbital compartment syndrome (OCS) is an emergent ophthalmic condition in which intraorbital pressure in the orbital compartment rises dramatically, compromising perfusion of the optic nerve and retina, leading to risk of irreversible vision loss. OCS occurs in the context of traumatic lesions with retrobulbar hemorrhage. Intraocular pressures (IOP) are measured via tonometry as a surrogate for intraorbital pressures, with emergent pathology being present when IOP exceeds 30-40 mmHg (normal being around 20 mmHg). What might be some physical exam findings beyond increased IOP for orbital compartment syndrome? Proptosis (physical outward protrusion of eye) with resistance to being pushed posterior. Afferent pupillary defect (when the non-impacted eye has light shown into it, the impacted eye will have pupillary constriction, and when light is removed it will begin to dilate, but when light is shown into the impacted eye, it will not constrict and continue to dilate). Generalized complaints of vision loss or an inability to move the eye. What is the treatment for orbital compartment syndrome? Lateral canthotomy must be performed immediately upon clinical suspicion as permanent vision loss can occur within minutes to hours.  Lateral canthotomy Step-by Step: Ideally have the patient sedated or highly cooperative. Numb and vasoconstrict the surrounding eye/orbital skin tissue with lidocaine and epinephrine. Take hemostats and clamp the interior and exterior eyelid at the lateral canthus at a 90º angle towards the orbital rim for 30-60 seconds to further devascularize the region. Take iris scissors and cut laterally to the orbital bone/rim to reveal the lateral lanthal tendon. Cut the inferior crus of the lateral lanthal tendon as this will provide the most significant reduction in IOP. Reassess IOP during each step of the procedure to measure procedure efficacy. If no pressure reduction is noted with inferior cantholysis, cutting the superior crus of the lateral canthal tendon may be required to further allow the eye to bulge out and reduce intraorbital pressure. Big takeaways? Ocular compartment syndrome is a rare but emergent vision threatening condition that requires immediate lateral canthotomy to reduce intraocular and intraorbital pressures. Lateral canthotomy done within 30-60 minutes of symptom development can save the patient from permanent vision loss. References: Mohammadi F, Rashan A, Psaltis A, et al. Intraocular Pressure Changes in Emergent Surgical Decompression of Orbital Compartment Syndrome. JAMA Otolaryngol Head Neck Surg. 2015;141(6):562-565. doi:10.1001/jamaoto.2015.0524 Haubner F, Jägle H, Nunes DP, et al. Orbital compartment: effects of emergent canthotomy and cantholysis. Eur Arch Otorhinolaryngol. 2015;272(2):479-483. doi:10.1007/s00405-014-3238-5 Bailey LA, van Brummen AJ, Ghergherehchi LM, Chuang AZ, Richani K, Phillips ME. Visual Outcomes of Patients With Retrobulbar Hemorrhage Undergoing Lateral Canthotomy and Cantholysis. Ophthalmic Plast Reconstr Surg. 2019;35(6):586-589. doi:10.1097/IOP.0000000000001401 Summarized by Dan Orbidan, OMS2 | Edited by Dan Orbidan and Jorge Chalit, OMS4 Donate: https://emergencymedicalminute.org/donate/

In this episode, we interview Danny Powell, an ocular melanoma (OM) patient whose tumor was identified early thanks to his eye doctor noticing a change and acting quickly. Danny explains his diagnosis, his treatment with brachytherapy, and how he later discovered that his grandmother also had OM—an extremely rare family connection. This prompted genetic testing, which revealed that Danny carries a BAP1 gene mutation. He discusses what that means for his ongoing care, his decision to join a clinical study, and the importance of regular surveillance scans. Whether you're an OM patient, caregiver, or medical professional, this episode provides practical insight into early detection, genetic risk factors, and patient involvement in research.

In this episode of the ESCRS IME podcast series on refractive surgery, Drs. Pooja Khamar and Béatrice Cochener examine postoperative surprises, focusing on how pre-existing ocular surface conditions, such as dry eye, can influence outcomes. They discuss its prevalence and impact on complications like pseudo-regression and glare from poor epithelial healing. The experts highlight the value of thorough preoperative assessments and targeted treatments for severe dryness. The episode also underscores patient education and shared decision-making, presenting best practices for ocular surface evaluation before surgery. Don't miss this insightful episode and be sure to check out the other expert-led podcasts in the series! Independent medical education supported by J&J (Silver), Zeiss (Silver), Tarsus (Bronze).

¿Te pican, se irritan o te lloran demasiado los ojos?

In this episode of the ESCRS IME podcast series on simultaneous vision IOLs, Drs. Francesco Carones and Andrea Janeková explain why a healthy ocular surface is essential before cataract refractive surgery. Even mild dry eye can skew keratometry readings and IOL calculations—yet it's often overlooked. Left untreated, dry eye can cause refractive surprises and postoperative dissatisfaction. The experts stress a thorough ocular surface evaluation and show how treating dry eye beforehand ensures more accurate results, better outcomes, and happier patients. Don't miss this insightful episode and be sure to check out the other expert-led podcasts in the series! Independent medical education supported by Alcon (Gold), J&J (Gold), B+L (Silver), Zeiss (Bronze).

In this call to action, Drs. Robert Mazzoli, Stuart Seiff, and Jon Perlstein share the scope of issues surrounding ophthalmic trauma care in the United States and a roadmap for improving it, including how we can translate experiences from the military into our own set of Damage Control Ophthalmology (DCO) guidelines. Referenced article: A Call to Action and Roadmap for Improving Emergency Treatment of Ophthalmic Trauma in the United States For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Uday Devgan, MD, FACS, FRCS, speaks with Christopher E. Starr, MD, FACS, and Brian Shafer, MD, in two short segments drawn from CRST's October cover focus, "Refractive Cataract Roundtables." Dr. Starr reviews a practical approach to preoperative ocular surface optimization—key exam steps, stop-rules before biometry, and simple readiness markers. Dr. Shafer outlines his IOL decision framework, balancing spectacle independence and image quality, who is not a candidate for diffractive optics, and options for residual refractive error. Related perspectives appear in the October issue of CRST.

Jaume Segalés y los responsables de Mundo Natural hablan de salud y de la salud ocular.

In this episode, Kelly Knickelbein, VMD, DACVO, joined us to discuss ocular squamous cell carcinoma in horses, including clinical signs, risk factors, treatment options, prevention strategies, and more. She also briefly discussed her current research on genetic cataracts in horses. This episode of Disease Du Jour is brought to you by Equithrive.GUESTS AND LINKS - EPISODE 169Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)Guest: Dr. Kelly Knickelbein, VMD, DACVOPodcast Website: Disease Du JourThis episode of Disease Du Jour podcast is brought to you by Equithrive.Connect with the Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)

Please visit answersincme.com/XCG860 to participate, download slides and supporting materials, complete the post test, and obtain credit. This educational activity brings together leading experts in ophthalmology and oncology to explore clinical strategies for managing ocular adverse events associated with a novel class of therapies for advanced breast cancer: the oral selective estrogen receptor degraders (SERDs). Faculty will share key insights and practical guidance on identifying and managing common ocular side effects—particularly photopsia and dry eye—with the goal of enhancing patient care and improving quality of life for individuals navigating survivorship with advanced breast cancer. Upon completion of this activity, participants should be better able to: Recognize the implications of using oral SERDs in HR-positive, HER2-negative breast cancer for ophthalmic practice; Describe the ocular toxicities associated with oral SERDs used in breast cancer treatment; and Apply multidisciplinary strategies to facilitate the detection and management of ocular toxicities in patients receiving oral SERDs.

In this episode, Kelly Knickelbein, VMD, DACVO, joined us to discuss ocular squamous cell carcinoma in horses, including clinical signs, risk factors, treatment options, prevention strategies, and more. She also briefly discussed her current research on genetic cataracts in horses. This episode of Disease Du Jour is brought to you by Equithrive.GUESTS AND LINKS - EPISODE 169Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)Guest: Dr. Kelly Knickelbein, VMD, DACVOPodcast Website: Disease Du JourThis episode of Disease Du Jour podcast is brought to you by Equithrive.Connect with the Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)

In this inspiring episode of the Eye Believe Podcast

GLP-1 receptor agonists have revolutionized the treatment of diabetes and obesity, but recent data suggest a potential link to a higher risk of various ocular disorders, especially with long-term use. This episode reviews the findings of these studies, places them in context with the overall benefits of GLP-1s, and covers what pharmacists should know when counseling patients. Listen in to enhance your ability to guide safe, informed medication choices and stay updated on emerging safety information.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJamie Pitlick, PharmD, BCPS, BC-ADMProfessor and Chair of Pharmacy PracticeDrake University College of Pharmacy and Health SciencesJoshua Davis Kinsey and Jamie Pitlick have no relevant financial relationships with ineligible companies to disclose.Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the potential relationship between GLP-1 receptor agonist use and the development of ocular disorders.2. Identify key considerations for pharmacist counseling related to GLP-1 therapy and ocular health.0.05 CEU/0.5 HrUAN: 0107-0000-25-311-H01-PInitial release date: 10/27/2025Expiration date: 10/27/2026Additional CPE details can be found here.

This podcast was created using NotebookLM.This podcast focus on the issue of ocular surface pain, highlighting its prevalence and the challenges associated with its treatment.

GLP-1 receptor agonists have revolutionized the treatment of diabetes and obesity, but recent data suggest a potential link to a higher risk of various ocular disorders, especially with long-term use. This episode reviews the findings of these studies, places them in context with the overall benefits of GLP-1s, and covers what pharmacists should know when counseling patients. Listen in to enhance your ability to guide safe, informed medication choices and stay updated on emerging safety information. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJamie Pitlick, PharmD, BCPS, BC-ADMProfessor and Chair of Pharmacy PracticeDrake University College of Pharmacy and Health SciencesJoshua Davis Kinsey and Jamie Pitlick have no relevant financial relationships with ineligible companies to disclose.  Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the potential relationship between GLP-1 receptor agonist use and the development of ocular disorders.2. Identify key considerations for pharmacist counseling related to GLP-1 therapy and ocular health.0.05 CEU/0.5 HrUAN: 0107-0000-25-311-H01-PInitial release date: 10/27/2025Expiration date: 10/27/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

La mayoría de la población padece problemas de refracción en la vista, que son aquellos relacionados con la manera en que enfoca el ojo, como miopía, hipermetropía o astigmatismo, entre otros. El sentido de la vista es el que permite al hombre conocer el medio que lo rodea, relacionarse con sus semejantes, y el hombre debe contar con los elementos adecuados para captar e interpretar señales provenientes de aquellos. Las imágenes visuales le proporcionan a través del ojo, información sobre el color, la forma, la distancia, posición y movimiento de los objetos. El deterioro de la vista se convierte a menudo en un serio problema para las personas de edad avanzada. Si su visión está disminuyendo, considere el uso suplementario cuya función en la bioquímica y fotoquímica contribuye a una mejor visión. Ocular está científicamente diseñado para este propósito. Aporta todos los antioxidantes y bioflavonoides activos que protegen la vista.

Tracy Doll, OD, FAAO, joins co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, on this episode of To the Point to share her expertise with the aesthetics side of managing ocular surface disease. Dr. Doll discusses her experiences addressing patients' clinical and aesthetic concerns, educating patients and other providers on the cosmetic benefits of certain dry eye therapies, integrating new innovations in her clinic, and more.

Dr. Grossman shares a new complete ocular nutrition spray and explains why oral absorption can outperform tablets for delivering eye-protective nutrients. From lutein and zeaxanthin to ginkgo and bilberry, we discuss the ingredients in Dr. Grossman's Complete Eye Formula Oral Spray. These ingredients were carefully selected to support the retina, blood flow, and everyday visual comfort.• who benefits most from ocular nutrition support • why an oral spray delivery can increase absorption • key carotenoids for macular defense • taurine and alpha lipoic acid for oxidative protection • ginkgo for ocular blood flow and visual fields • bilberry for night vision, focus and screen fatigue • quercetin and rutin for inflammation and capillary strength • simple dosing, usage tips and consistencyThe product is located at: https://store.naturaleyecare.com/drgcompleteye-oral-spray.htmlFor more information, visit naturaleyecare.com and drgrossman2020.com. Email us at info@naturaleyecare.com or call 845 475 4158. If you don't already subscribe to this podcast, please subscribe and review us.

Ocular complaints in children, such as a red or painful eye, sudden vision changes, or difficulty opening one eye, may be more than a minor concern. In pediatrics, these presentations can progress rapidly, and timely recognition is critical to preventing long-term vision impairment. A focused five-minute eye examination can often distinguish between emergent, urgent and routine conditions, making early assessment and intervention essential in the primary care setting.  This episode was recorded on the exhibit floor at the 2025 American Academy of Pediatrics National Conference in Denver, Colorado. Our guest is Donny Suh, MD, Professor of Ophthalmology and Chief of Pediatric Ophthalmology at the University of California, Irvine, and Children's Hospital of Orange County.  Some highlights from this episode include:  What a pediatrician can learn in five minutes  The most common ocular injuries that pediatrician's encounter  How pediatricians can support a patient before sending to a specialist  How understanding a patient's history can help a pediatrician For more information on Children's Colorado, visit: childrenscolorado.org. 

What happens when you start teaching for connection? In this conversation with Dr. Tabitha Kenlon, an English professor who teaches students across the world (including in Afghanistan), we explore what it really means to see one another when sight isn't the main channel. Tabitha shares how her experiences with low vision reshaped her classroom, and how vulnerability, curiosity, and access can transform both teaching and storytelling. We talk about authority as a bridge instead of a throne, about “sprinkling” inclusion instead of siloing it, and how risk can become an act of generosity. You'll hear insights that reach far beyond education: from redefining presence to building authentic connection in spaces where visuals fall short. If you've ever wondered what inclusion sounds like in practice, this episode is a masterclass in human-centered connection.

What if the brain fog you're experiencing isn't just tiredness—but your nervous system's way of disconnecting you from an unbearable reality? In this mini episode, Dr. Aimie Apigian answers a question from Rachel, a therapist in Seattle, about why the freeze response is associated with brain fog. Many people think of the freeze response as simply paralysis, not understanding the sophisticated biological mechanisms happening at the cellular level. This episode dives deep into the freeze response—when it happens, why it happens, and the brain inflammation that creates the disconnection and fog we experience. Understanding this biology helps us recognize when we or someone we're working with has a chronic functional freeze, so we know where to start with healing. In this episode you'll hear more about: The five steps the body takes to go into a trauma response—starting with activation and crossing the critical line of overwhelm The two reasons we cross that critical line: "too much too fast" (excessive activation) and "too little for too long" (prolonged stress without recovery) Why your nervous system decides certain situations are life threats—even when logically they're not (like being berated in residency or hearing hurtful words from someone you care about) The cellular biology of brain fog: How immune cells in your brain (microglia) unleash inflammation, cytokines, and chemokines that create the mental disconnection and fog The surreal feeling of freeze: Why voices sound distant, why you feel like you're in a daze, and why people around you seem far away even though they're right there Chronic functional freeze: The state where you're still functioning and going through life, but secretly wanting to hide, using substances like caffeine or food (especially histamine-producing foods) to push through Why anxiety is often your body fighting the freeze—using stress to stay out of shutdown, which is why relief from anxiety can sometimes make you fall into that heaviness The brain inflammation protocol: Specific nutrients and practices to keep your microglia in their resting state, including NAC, magnesium L-threonate, luteolin, GABA, resveratrol, and turmeric Ocular-cardiac reflex (eye support): A simple but powerful tool where gently pressing on closed eyes activates the vagus nerve for immediate calm Why starting with the freeze is essential—opening up the chronic functional freeze gives you more energy to dedicate to the healing journey Dr. Aimie's personal story of a biking accident and concussion—experiencing the freeze response firsthand as she regained consciousness on the sidewalk The freeze response isn't weakness or paralysis—it's your nervous system's sophisticated survival strategy when it perceives a life threat. Brain fog is always part of the freeze response, created by immune cells in your brain that help you disconnect from unbearable reality. Understanding this biology helps you recognize the freeze in yourself or others, and know that working with it is where healing must start.

Featuring an interview with Dr Neel Pasricha, including the following topics: Anatomy and physiology of the cornea; intersection of ophthalmology and oncology for patients receiving antibody-drug conjugates (ADCs) (0:00) Association of corneal toxicities with ADCs (4:56) Dose and schedule modifications to mitigate ocular toxicities associated with belantamab mafodotin and other ADCs (9:02) Spectrum and severity of corneal toxicities associated with datopotamab deruxtecan (14:44) Role of optometrists and ophthalmologists in screening for and management of ocular toxicities (17:55) Other ocular toxicities associated with cancer therapies (24:26) Prevention and management of corneal toxicity (33:58) Preexisting ophthalmic conditions as potential risk factors for development of ocular toxicities with ADCs (43:39) General clinical pearls on the management of ocular toxicities with cancer therapies (48:04) CME information and select publications

Dr Neel Pasricha from the University of California, San Franciso, reviews corneal and other ophthalmic toxicities associated with antibody-drug conjugates and other cancer therapies and strategies for their prevention and management. CME information and select publications here.

Dr Neel Pasricha from the University of California, San Franciso, reviews corneal and other ophthalmic toxicities associated with antibody-drug conjugates and other cancer therapies and strategies for their prevention and management. CME information and select publications here.

Featuring perspectives from Prof Rebecca A Dent, Dr Hans Lee, Dr Neel Pasricha and Dr Tiffany A Richards, including the following topics:  Introduction: The Patient Experience (0:00) Managing Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies — Dr Pasricha (10:28) Ocular Toxicities in Multiple Myeloma (45:33) Ocular Toxicities in Breast Cancer (50:34) CME information and select publications

Prof Rebecca A Dent from National Cancer Centre Singapore, Dr Hans Lee from Sara Cannon Research Institute in Nashville, Tennessee, Dr Neel Pasricha from the University of California, San Francisco, and Dr Tiffany A Richards from The University of Texas MD Anderson Cancer Center in Houston, discuss strategies to manage ocular toxicities associated with antibody-drug conjugates and other cancer therapies. CME information and select publications here.

Barry talks about the importance of perspective. The first step is to admit we are flawed perceivers. However, once we do that it doesn't mean that we are wrong, that nothing can be known, or that someone else is right.     Link/Article: Target scales back on its LGBTQ+ merchandise ahead of Pride Month 2024, Target […]

Crawling is a foundational developmental milestone that does more than just strengthen muscles — it plays a critical role in developing the visual system, especially ocular motor skills such as tracking, convergence, and coordinated eye movements.We're diving into why crawling is essential and how to help children of ALL ages crawl! LINKSWe'd love to answer your questions on the podcast! Fill out this form - https://harkla.typeform.com/to/ItWxQNP3 Early Intervention Blueprint https://harkla.co/products/infant-sensory-development-courseCrawling for Brain Development https://sensationalbrain.com/product/crawling-brain-development-curriculum/All Things Sensory Podcast Instagram https://www.instagram.com/allthingssensorypodcast/Harkla Website https://harkla.co/Harkla YouTubehttps://www.youtube.com/c/HarklaFamilyHarkla Instagramhttps://www.instagram.com/harkla_family/

Is your child/client constantly skipping words while reading, losing their place on the page, or avoiding reading altogether? These might not be “reading problems”—they could be visual problems.In this episode, we break down how ocular motor skills—specifically saccades, pursuits, and convergence—are essential for reading success. You'll learn how these visual skills impact everything from decoding to attention span, and why children with ADHD, sensory processing disorder, or retained primitive reflexes are at higher risk for visual-motor challenges.LINKSRelationship Between Ocular Motility and Motor Skillshttps://pmc.ncbi.nlm.nih.gov/articles/PMC11698614/Primitive Reflex Integration and Reading in the Classroomhttps://jneuroscience.com/2023/02/26/primitive-reflex-integration-and-reading-achievement-in-the-classroom/Statistics of Infants' Natural Visual Experience https://jov.arvojournals.org/article.aspx?articleid=2792416We'd love to answer your questions on the podcast! Fill out this form - https://harkla.typeform.com/to/ItWxQNP3 All Things Sensory Podcast Instagram https://www.instagram.com/allthingssensorypodcast/Harkla Website https://harkla.co/Harkla YouTubehttps://www.youtube.com/c/HarklaFamilyHarkla Instagramhttps://www.instagram.com/harkla_family/

In this episode, we break down what ocular motor skills really are, how they affect your child's behavior and development, and most importantly simple at-home activities you can start using right away to help.They also share how retained primitive reflexes, screen time, and missed developmental milestones can all impact how your child's eyes work together — and why this often goes unnoticed.Whether you're a parent, therapist, or educator, this episode is full of practical tools you can start today. Here's what you'll learn: What ocular motor skills really are (hint: it's not just 20/20 vision!)Signs your child might be struggling with visual tracking or coordinationEasy, playful at-home activities for:Saccades (eye jumping)Pursuits (smooth tracking)Convergence & divergence (eye teaming)How primitive reflexes and screen time impact visionTips for building a consistent and doable home exercise routineAnd, we'll answer a listener question at the end of the episode. Happy listening! LINKSWe'd love to answer your questions on the podcast! Fill out this form - https://harkla.typeform.com/to/ItWxQNP3 Ocular Motor Skills Screening Videohttps://www.youtube.com/watch?v=LMSVhwIL5wI&t=11sAssessing Primitive Reflexes Videohttps://www.youtube.com/watch?v=ZkGDm3t2hb8&t=1sBrock String Instructionshttps://www.optometrists.org/vision-therapy/guide-to-vision-therapy/vision-therapy-faqs/how-is-a-brock-string-used/Spot Ithttps://www.spotitgame.com/Zoomballhttps://www.amazon.com/Toysmith-6219-Zip-Ball/dp/B00E6DXQU8/ref=sr_1_3?dib=eyJ2IjoiMSJ9.9wtOAvhcy8jgIIeXS3esac48UmRrA0araB1icT_BW19b5HZVhEuyaKG-Ol5vGUNVEPSfO1x7UHrpflm1GmNTMLbeaernwnXIy-Dku7CqPUBlD9pnMEHeFNF54jWVJcgWOa_UXJ7HbqnmbqssbFeU-NfwXZH5MN1xLnOP5z6dFqN5X0yr4OzQ3EVyl155PjJ6sInCbUUCcQoLp70CERAeNxnQ1wiE6p-IZb6Gd_SrrjT-JrbMONntd9tdIflCvBKEl2mlfk6wwc-Jj20SJKoRAc8LZCOieWhOYy5zQBC9VLA.i5FuA9BWsSe4NReui8vk3vdZFtEmEpBd_hPz8xfAfHc&dib_tag=se&keywords=zoom%2Bball&qid=1752800406&refinements=p_72%3A1248963011&rnid=1248961011&s=toys-and-games&sr=1-3&th=1A Balanced Brain Full Digital Coursehttps://harkla.co/products/balanced-brainEarly Intervention Blueprint Full Digital Course https://harkla.co/products/infant-sensory-development-courseAll Things Sensory Podcast Instagram https://www.instagram.com/allthingssensorypodcast/Harkla Website https://harkla.co/Harkla YouTubehttps://www.youtube.com/c/HarklaFamilyHarkla Instagram